L\u2019OM\u00e9DIT Centre-Val de Loire (CVdL) annonce la mise \u00e0 disposition de nouveaux documents et la mise \u00e0 jour de ressources existantes, \u00e9labor\u00e9s de mani\u00e8re collaborative avec les professionnels de sant\u00e9 de la r\u00e9gion impliqu\u00e9s dans ses commissions techniques et groupes de travail. Les lieux de classement de ces documents sur le site de l\u2019OM\u00e9DIT sont pr\u00e9cis\u00e9s pour en faciliter l\u2019acc\u00e8s. Les professionnels de sant\u00e9 de la r\u00e9gion CVdL int\u00e9ress\u00e9s pour rejoindre une commission sont invit\u00e9s \u00e0 se rendre sur la page \u00ab Comit\u00e9s techniques et groupes de travail \u00bb.<\/p>\n
Plusieurs nouveaux supports, li\u00e9s au r\u00e9f\u00e9rentiel de certification de la Haute Autorit\u00e9 de sant\u00e9 (HAS, version 2025 \u2013 6e cycle), sont publi\u00e9s. Il s\u2019agit d\u2019affiches\/slogans portant sur la prise en charge en p\u00e9rinatalit\u00e9 (crit\u00e8res imp\u00e9ratifs 2.3-10 et 2.3-11, septembre 2026), sur l\u2019administration des m\u00e9dicaments et l\u2019interruption de t\u00e2che (crit\u00e8re imp\u00e9ratif 2.2-05, septembre 2026) et sur la d\u00e9claration et le traitement des erreurs m\u00e9dicamenteuses (crit\u00e8res imp\u00e9ratif et standard, septembre 2026). Cette derni\u00e8re affiche a \u00e9t\u00e9 \u00e9labor\u00e9e en collaboration avec la structure r\u00e9gionale d\u2019appui QUALIRIS et est accessible dans la rubrique \u00ab Bon usage M\u00e9dicaments \u00bb > \u00ab Certification des \u00e9tablissements sanitaires \u00bb. Deux documents destin\u00e9s aux patients sont \u00e9galement diffus\u00e9s dans la page \u00ab Patients \u00bb > \u00ab Semaine S\u00e9curit\u00e9 Patient \u00bb : une affiche \u00ab Je sors de l\u2019h\u00f4pital, je fais le point sur mon traitement \u00bb (septembre 2026) et un support visant \u00e0 s\u00e9curiser la continuit\u00e9 du traitement des patients chroniques entre l\u2019h\u00f4pital et la ville (septembre 2026).<\/p>\n
Parmi les ressources actualis\u00e9es, un module de e\u2011learning consacr\u00e9 aux anticoagulants oraux directs (AOD) dans le cadre des \u00ab never events \u00bb est mis \u00e0 jour : \u00ab Pr\u00e9venir les erreurs li\u00e9es aux Anticoagulants Oraux Directs \u00bb (octobre 2026). Il est accessible via la page \u00ab Bon usage M\u00e9dicaments \u00bb > \u00ab Never events\/M\u00e9dicaments \u00e0 risque \u00bb, ainsi que depuis la page d\u2019accueil du site, rubrique \u00ab Focus sur : FORMATIONS \u2013 E\u2011LEARNING, WEBINAIRES \u00bb, onglet \u00ab M\u00e9dicaments \u00bb. Un autre e\u2011learning actualis\u00e9 concerne la promotion par les \u00e9tablissements de sant\u00e9 de l\u2019auto\u2011administration des m\u00e9dicaments par le patient hospitalis\u00e9 (PAAM), en lien avec le crit\u00e8re avanc\u00e9 2.2-07 du r\u00e9f\u00e9rentiel HAS, co\u2011port\u00e9 par les r\u00e9gions Normandie et Centre-Val de Loire (septembre 2026). La pr\u00e9sentation de ce module a fait l\u2019objet d\u2019un webinaire, \u00e9galement mis \u00e0 disposition. Ces ressources sont r\u00e9f\u00e9renc\u00e9es dans la rubrique \u00ab Bon usage M\u00e9dicaments \u00bb > \u00ab Certification des \u00e9tablissements sanitaires \u00bb (section \u00ab ADMINISTRATION \u00bb). Enfin, des affiches\/slogans sur la prescription conditionnelle \u00ab si besoin \u00bb (crit\u00e8res imp\u00e9ratifs 1.1-05, r\u00e9f\u00e9rentiel HAS v2025) sont \u00e9galement mentionn\u00e9es parmi les outils li\u00e9s \u00e0 la certification.\u00a0(contenu r\u00e9sum\u00e9 par l’IA)Lire la Suite<\/a><\/p>","protected":false},"excerpt":{"rendered":" L\u2019OM\u00e9DIT Centre-Val de Loire (CVdL) annonce la mise \u00e0 disposition de nouveaux documents et la mise \u00e0 jour de ressources existantes, \u00e9labor\u00e9s de mani\u00e8re collaborative avec les professionnels de sant\u00e9 […]<\/p>\n","protected":false},"author":1,"featured_media":9774,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[7],"tags":[224,227],"class_list":["post-19707","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicaments-et-produits-de-sante","tag-omedit","tag-ia"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/19707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19707"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/19707\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/9774"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}